Intensive therapies for mantle cell lymphoma: time for a disease-specific approach?

Leuk Lymphoma. 2010 Mar;51(3):357-9. doi: 10.3109/10428191003672149.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, Neoplasm / biosynthesis
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cell Line, Tumor
  • Clinical Trials as Topic
  • Follow-Up Studies
  • Humans
  • Ki-67 Antigen / biosynthesis
  • Lymphoma, Mantle-Cell / therapy*
  • Medical Oncology / methods*
  • Middle Aged
  • Rituximab
  • Time Factors
  • Translocation, Genetic
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, Neoplasm
  • Ki-67 Antigen
  • Rituximab